Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma

Cancer Genetics

Volumn 208, Issue 10, 2015, Pages 482-491

  Zhang, Hong ^a   Ye, Junyi ^a   Weng, Xiaoling ^a   Liu, Fatao ^b   He, Lin ^a,b   Zhou, Daizhan ^c   Liu, Yun ^a  

^a FUDAN UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Alternative splicing; Differentially expressed genes; Gene fusion; Hepatocellular carcinoma; Portal vein tumor thrombus

Indexed keywords

CELL SURFACE RECEPTOR; EXTRACELLULAR MATRIX RECEPTOR; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG; ONCOPROTEIN; RIBOSOME PROTEIN; RPS24 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ARID1A GENE; ARTICLE; C9ORF3 GENE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FUSION GENE; GENE EXPRESSION; GPATCH3 GENE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MDM1 GENE; METASTASIS POTENTIAL; NUP107 GENE; ONCOGENE; PORTAL VEIN; PORTAL VEIN TUMOR THROMBUS; PRIORITY JOURNAL; PRLR GENE; PROTEIN INTERACTION; PTGES3 GENE; QUANTITATIVE ANALYSIS; RARG GENE; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; TERT GENE; TMC1 GENE; TRANSCRIPTOMICS; TUMOR THROMBUS; COMPARATIVE STUDY; COMPLICATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; PROCEDURES; PROGNOSIS; TUMOR INVASION; VENOUS THROMBOSIS;

CARCINOMA, HEPATOCELLULAR; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS, FUSION; PORTAL VEIN; PROGNOSIS; RIBOSOMAL PROTEINS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME; VENOUS THROMBOSIS;

EID: 84942499920     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2015.06.002     Document Type: Article

References (49)

1. Yamakado K., Kudo M. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona clinic liver cancer stage B). Oncology 2014, 87(suppl 1):78-81.
2. Leng J.J., Xu Y.Z., Dong J.H. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis. ANZ J Surg 2014, 10.1111/ans.12803.
3. Nordenstedt H., White D.L., El-Serag H.B. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010, 42(suppl 3):S206-S214.
4. Liu S., Guo W., Shi J., et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 2012, 56:389-396.
5. Yang P., Li Q.J., Feng Y., et al. TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 2012, 22:291-303.
6. Rongrui L., Na H., Zongfang L., et al. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis. Curr Pharm Des 2014, 20:1715-1725.
7. Hinrichsen I., Kemp M., Peveling-Oberhag J., et al. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs. PLoS ONE 2014, 9:e84453.
8. Zhang L., Lu W., Miao X., et al. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis 2003, 24:1039-1044.
9. Duan C., Zhang W., Lu J., et al. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk. Tumour Biol 2013, 34:2827-2834.
10. Guerrieri F., Belloni L., Pediconi N., et al. Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis 2013, 33:147-156.
11. Hsieh Y.H., Hsu J.L., Su I.J., et al. Genomic instability caused by hepatitis B virus: into the hepatoma inferno. Front Biosci (Landmark Ed) 2011, 16:2586-2597.
12. Huang J., Deng Q., Wang Q., et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet 2012, 44:1117-1121.
13. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615.
14. Sowalsky A.G., Xia Z., Wang L., et al. Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol Cancer Res 2015, 13:98-106.
15. Ding X., Zhu L., Ji T., et al. Long intergenic non-coding RNAs (LincRNAs) identified by RNA-seq in breast cancer. PLoS ONE 2014, 9:e103270.
16. Takai A., Dang H.T., Wang X.W. Identification of drivers from cancer genome diversity in hepatocellular carcinoma. Int J Mol Sci 2014, 15:11142-11160.
17. Jhunjhunwala S., Jiang Z., Stawiski E.W., et al. Diverse modes of genomic alteration in hepatocellular carcinoma. Genome Biol 2014, 15:436.
18. Ren S., Peng Z., Mao J.H., et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 2012, 22:806-821.
19. Kim S.C., Jung Y., Park J., et al. A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers. PLoS ONE 2013, 8:e55596.
20. Bolger A.M., Lohse M., Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 2014, 30:2114-2120.
21. Trapnell C., Roberts A., Goff L., et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012, 7:562-578.
22. Langmead B., Trapnell C., Pop M., et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25.
23. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol 2010, 11:R106.
24. Katz Y., Wang E.T., Airoldi E.M., et al. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 2010, 7:1009-1015.
25. Ye J., Yang Z., Li C., et al. NF-kappaB signaling and vesicle transport are correlated with the reactivation of the memory trace of morphine dependence. Diagn Pathol 2014, 9:142.
26. Wang Y., Gogol-Doring A., Hu H., et al. Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation. EMBO Mol Med 2013, 5:1431-1442.
27. Kim D., Salzberg S.L. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol 2011, 12:R72.
28. Wang L., Wang S., Li W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 2012, 28:2184-2185.
29. Anders S., Pyl P.T., Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 2015, 31:166-169.
30. Dennis G., Sherman B.T., Hosack D.A., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4:P3.
31. Isserlin R., Merico D., Voisin V., et al. Enrichment Map-a Cytoscape app to visualize and explore OMICs pathway enrichment results. F1000Res 2014, 3:141.
32. Tu K., Zheng X., Dou C., et al. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma. Int J Mol Sci 2014, 15:20486-20499.
33. Cheung K.F., Zhao J., Hao Y., et al. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor gamma in suppressing hepatocellular carcinoma cell growth. Cancer 2013, 119:1217-1226.
34. Kurokawa T., Shimomura Y., Bajotto G., et al. Peroxisome proliferator-activated receptor alpha (PPARalpha) mRNA expression in human hepatocellular carcinoma tissue and non-cancerous liver tissue. World J Surg Oncol 2011, 9:167.
35. Mishra P., Paramasivam S.K., Thylur R.P., et al. Peroxisome proliferator-activated receptor gamma ligand-mediated apoptosis of hepatocellular carcinoma cells depends upon modulation of PI3Kinase pathway independent of Akt. J Mol Signal 2010, 5:20.
36. Yang Z.H., Zheng R., Gao Y., et al. Abnormal gene expression and gene fusion in lung adenocarcinoma with high-throughput RNA sequencing. Cancer Gene Ther 2014, 21:74-82.
37. Edgren H., Murumagi A., Kangaspeska S., et al. Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol 2011, 12:R6.
38. Aldrighetti L., Pulitano C., Catena M., et al. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion. Ann Surg Oncol 2009, 16:1254.
39. Zhang J., Pan Y.F., Ding Z.W., et al. RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription. Oncogene 2015, 34:1575-1583.
40. Jarvelainen H., Sainio A., Koulu M., et al. Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 2009, 61:198-223.
41. Lee S.K., Yi C.H., Kim M.H., et al. Genetic association between functional haplotype of collagen type III alpha 1 and chronic hepatitis B and cirrhosis in Koreans. Tissue Antigens 2008, 72:539-548.
42. Lai K.K., Shang S., Lohia N., et al. Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet 2011, 7:e1002147.
43. Yi J.M., Dhir M., Van Neste L., et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res 2011, 17:1535-1545.
44. Xu W.B., Roufa D.J. The gene encoding human ribosomal protein S24 and tissue-specific expression of differentially spliced mRNAs. Gene 1996, 169:257-262.
45. Gazda H.T., Grabowska A., Merida-Long L.B., et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet 2006, 79:1110-1118.
46. Yuan S.X., Yang F., Yang Y., et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology 2012, 56:2231-2241.
47. Wu Y., Wang X., Wu F., et al. Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing. PLoS ONE 2012, 7:e41001.
48. Tomlins S.A., Rhodes D.R., Perner S., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310:644-648.
49. Soda M., Choi Y.L., Enomoto M., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.